1. Home
  2. PHX vs IVA Comparison

PHX vs IVA Comparison

Compare PHX & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHX
  • IVA
  • Stock Information
  • Founded
  • PHX 1926
  • IVA 2011
  • Country
  • PHX United States
  • IVA France
  • Employees
  • PHX N/A
  • IVA N/A
  • Industry
  • PHX Oil & Gas Production
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • PHX Energy
  • IVA Health Care
  • Exchange
  • PHX Nasdaq
  • IVA Nasdaq
  • Market Cap
  • PHX 126.0M
  • IVA 117.3M
  • IPO Year
  • PHX N/A
  • IVA 2020
  • Fundamental
  • Price
  • PHX $3.44
  • IVA $1.70
  • Analyst Decision
  • PHX Strong Buy
  • IVA Strong Buy
  • Analyst Count
  • PHX 2
  • IVA 3
  • Target Price
  • PHX $4.90
  • IVA $18.00
  • AVG Volume (30 Days)
  • PHX 50.0K
  • IVA 12.9K
  • Earning Date
  • PHX 11-06-2024
  • IVA 09-25-2024
  • Dividend Yield
  • PHX 4.63%
  • IVA N/A
  • EPS Growth
  • PHX N/A
  • IVA N/A
  • EPS
  • PHX 0.15
  • IVA N/A
  • Revenue
  • PHX $33,407,691.00
  • IVA $20,652,523.00
  • Revenue This Year
  • PHX $5.74
  • IVA N/A
  • Revenue Next Year
  • PHX $22.86
  • IVA $469.85
  • P/E Ratio
  • PHX $22.72
  • IVA N/A
  • Revenue Growth
  • PHX N/A
  • IVA N/A
  • 52 Week Low
  • PHX $2.95
  • IVA $1.53
  • 52 Week High
  • PHX $3.81
  • IVA $4.75
  • Technical
  • Relative Strength Index (RSI)
  • PHX 60.12
  • IVA 29.90
  • Support Level
  • PHX $3.37
  • IVA $1.77
  • Resistance Level
  • PHX $3.45
  • IVA $1.92
  • Average True Range (ATR)
  • PHX 0.06
  • IVA 0.12
  • MACD
  • PHX 0.00
  • IVA -0.03
  • Stochastic Oscillator
  • PHX 80.00
  • IVA 18.00

About PHX PHX Minerals Inc.

PHX Minerals Inc is an oil and natural gas mineral company that has employed a plan to shift the core of its business away from drilling and toward perpetual mineral and natural gas ownership. The company owns substantial mineral acreage, principally in Oklahoma, North Dakota, Texas, New Mexico, and Arkansas, but still maintains legacy interests in natural gas and oil properties that have retired operations. The revenues is derived from royalties granted from the production and sale of natural gas, oil and NGL, and the remaining portion of its revenues is derived from the production and sale of natural gas, oil and NGL on its working interests.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: